Lobular carcinoma of the breast and response to targeted therapy with CDK4/6 inhibitors – a single Portuguese center experience. (November 2022) - Freitas, P.; Pina, A.T.; Carola, S.; Cardoso, C.; Gouveia, E.; Vaz, F.; Santos, M.; Mira, M.B.; Alexandre, M.T.; Miguel, I.; Brito, M.; Moreira, A.; et al.